Difolta injection 20mg, manufactured by Mundipharma, contains Pralatrexate and is an injectable drug with YJ code 4229404A1027, provided as 20mg in 1mL per bottle. This medicine is primarily used to treat recurrent or refractory peripheral T-cell lymphoma by inhibiting dihydrofolate reductase to disrupt DNA synthesis in tumor cells.
Difolta injection 20mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →